JP2006519842A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2006519842A5 JP2006519842A5 JP2006506985A JP2006506985A JP2006519842A5 JP 2006519842 A5 JP2006519842 A5 JP 2006519842A5 JP 2006506985 A JP2006506985 A JP 2006506985A JP 2006506985 A JP2006506985 A JP 2006506985A JP 2006519842 A5 JP2006519842 A5 JP 2006519842A5
- Authority
- JP
- Japan
- Prior art keywords
- cancer
- hydrogen atom
- carbon atoms
- unbranched
- compound
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US45295103P | 2003-03-10 | 2003-03-10 | |
| US47492903P | 2003-06-03 | 2003-06-03 | |
| PCT/US2004/007144 WO2004080408A2 (en) | 2003-03-10 | 2004-03-10 | Method of treating cancer with azaspirane compositions |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2006519842A JP2006519842A (ja) | 2006-08-31 |
| JP2006519842A5 true JP2006519842A5 (https=) | 2007-06-14 |
Family
ID=32994468
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2006506985A Withdrawn JP2006519842A (ja) | 2003-03-10 | 2004-03-10 | アザスピラン化合物による癌治療法 |
Country Status (7)
| Country | Link |
|---|---|
| US (2) | US20050250801A1 (https=) |
| EP (1) | EP1610806A4 (https=) |
| JP (1) | JP2006519842A (https=) |
| CA (1) | CA2518357A1 (https=) |
| MX (1) | MXPA05009708A (https=) |
| TW (1) | TW200505438A (https=) |
| WO (1) | WO2004080408A2 (https=) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2447281B1 (en) * | 2005-03-24 | 2015-12-16 | ThromboGenics N.V. | Novel anti-PLGF antibody |
| US20080247964A1 (en) * | 2006-05-08 | 2008-10-09 | Yuelian Xu | Substituted azaspiro derivatives |
| EP2142498A2 (en) * | 2007-04-02 | 2010-01-13 | Institute for Oneworld Health | Cftr inhibitor compounds and uses thereof |
| EP2192904B1 (en) * | 2007-08-27 | 2016-08-17 | Auxagen, Inc. | METHODS FOR INHIBITING TGF-beta |
| US8236838B2 (en) * | 2008-04-21 | 2012-08-07 | Institute For Oneworld Health | Compounds, compositions and methods comprising isoxazole derivatives |
| US20090264433A1 (en) * | 2008-04-21 | 2009-10-22 | Institute For Oneworld Health | Compounds, Compositions and Methods Comprising Triazine Derivatives |
| WO2009131947A2 (en) * | 2008-04-21 | 2009-10-29 | Institute For Oneworld Health | Compounds, compositions and methods comprising pyridazine derivatives |
| US8207205B2 (en) * | 2008-04-21 | 2012-06-26 | Institute For Oneworld Health | Compounds, compositions and methods comprising oxadiazole derivatives |
| US8487006B2 (en) * | 2008-09-16 | 2013-07-16 | Auxagen, Inc. | Method of enhancing TGF-β signalling |
| US20110237528A1 (en) * | 2008-09-19 | 2011-09-29 | Institute For Oneworld Health | Compositions and methods comprising imidazole and triazole derivatives |
| US20100267706A1 (en) * | 2009-04-20 | 2010-10-21 | Institute For Oneworld Health | Compounds, Compositions and Methods Comprising Pyridazine Derivatives |
| US8343976B2 (en) * | 2009-04-20 | 2013-01-01 | Institute For Oneworld Health | Compounds, compositions and methods comprising pyrazole derivatives |
| EP2543812B1 (en) * | 2011-07-08 | 2014-11-05 | Welltec A/S | Downhole hydraulic pump |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4963557A (en) * | 1987-09-28 | 1990-10-16 | Smithkline Beecham Corporation | Immunomodulatory azaspiranes |
| US6051596A (en) * | 1990-08-10 | 2000-04-18 | Anormed, Inc. | Immunosuppressive compositions |
| ZA921120B (en) * | 1991-02-19 | 1993-01-27 | Smithkline Beecham Corp | Cytokine inhibitors |
| SG43383A1 (en) * | 1995-07-13 | 1997-10-17 | Smithkline Beecham Corp | N n-diethyl-8,8-dipropyl-2-azaspiro[4.5]decane-2- propanamine dimaleate |
| WO1997002820A1 (en) * | 1995-07-13 | 1997-01-30 | Anormed Inc. | N,n-dimethyl-8,8-dipropyl-2-azaspiro[4,5]decane-2-propanamine dimaleate |
| BR9709007A (pt) * | 1996-05-17 | 2000-01-04 | Anormed Inc | Uso de azaspirano substituìdo no tratamento da asma. |
-
2004
- 2004-03-10 CA CA002518357A patent/CA2518357A1/en not_active Abandoned
- 2004-03-10 MX MXPA05009708A patent/MXPA05009708A/es unknown
- 2004-03-10 US US10/796,292 patent/US20050250801A1/en not_active Abandoned
- 2004-03-10 EP EP04719198A patent/EP1610806A4/en not_active Withdrawn
- 2004-03-10 TW TW093106385A patent/TW200505438A/zh unknown
- 2004-03-10 JP JP2006506985A patent/JP2006519842A/ja not_active Withdrawn
- 2004-03-10 US US10/548,794 patent/US20070015780A1/en not_active Abandoned
- 2004-03-10 WO PCT/US2004/007144 patent/WO2004080408A2/en not_active Ceased
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP7028809B2 (ja) | コルテキソロン１７α－バレレートを含む腫瘍治療に用いるための組成物 | |
| TWI649081B (zh) | 治療固態腫瘤之方法 | |
| KR102112885B1 (ko) | B-raf 억제제, egfr 억제제 및 임의로 pi3k-알파 억제제를 포함하는 제약 조합물 | |
| JP2006519842A5 (https=) | ||
| JP2006519842A (ja) | アザスピラン化合物による癌治療法 | |
| KR20150132205A (ko) | B-Raf 억제제와 제2 억제제를 포함하는 조합 요법 | |
| CA2238283C (en) | Method for identifying compounds for inhibition of neoplastic lesions, pharmaceutical compositions from such compounds and uses of such compounds and compositions for treating neoplastic lesions | |
| UA119538C2 (uk) | Лікування злоякісної пухлини дигідропіразинопіразинами | |
| Khaleel et al. | Inhibitory effects of carbohydrazide indole derivative on micro-blood vessel growth using ex vivo, in vivo, and in vitro assays | |
| BR112021011699A2 (pt) | Terapia de combinação com um inibidor de raf e um inibidor de cdk4/6 para uso no tratamento contra câncer | |
| KR102337598B1 (ko) | 암 치료 방법 | |
| US20090259054A1 (en) | Methods and Compositions for the Treatment of Angiogenesis and Macular Degeneration | |
| CN117327067A (zh) | 一种小分子化合物epic-1042、药物组合物及其制备方法和应用 | |
| KR20180129795A (ko) | 렌바티닙 및 에베롤리무스를 사용한 신세포 암종의 치료 | |
| Kauntz | Cellular and molecular targets of silibinin, a natural flavonoid, in colorectal cancer prevention and therapy | |
| US6906064B2 (en) | Method for treating a patient with neoplasia using Iressa | |
| WO2006010073A1 (en) | Prevention of cancer | |
| TW202435890A (zh) | Raf抑制劑及kras g12c抑制劑組合療法 | |
| HK40018197A (en) | Pharmaceutical combinations comprising a b-raf inhibitor, an egfr inhibitor and optionally a pi3k-alpha inhibitor | |
| Keller et al. | 13C-MIXED TRIGLYCERIDE BREATH TEST (13C-MTG) DEMONSTRATES SUPERIORITY OF ENTERIC COATED MONOLITHIC ENZYME PREPARATION OVER PLACEBO: A MULTICENTRE, DOUBLE BLIND, PLACEBO CONTROLLED CROSS-OVER TRIAL | |
| US20030064421A1 (en) | Methods for treating a patient with neoplasia by administering cGMP-specific PDE-inhibiting compounds | |
| Schmitz-Winnenthal et al. | Selective expression of tumor associated antigens by samples derived from human pancreatic cancer | |
| Pour | Diabetes is not a predisposing factor for pancreatic cancer-new evidence | |
| Pfuetzer et al. | Combined nicotine and ethanol administration activates extracellular regulated kinase (ERK) in rat pancreatic AR4-2J cells |